(Q59350325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

author name string

Hongrui Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Zizhao Zhao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Jing Ling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Linhui Pan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Xibao Zhao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Huihui Zhu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Juan Yu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Bin Xie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Jianzhong Shen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

5 May 2020

language of work or name

English

0 references

publication date

22 November 2018

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

page(s)

42-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

Regulation of adaptive immunity by the innate immune system

5 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

USP14 activation promotes tumor progression in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

IRTKS negatively regulates antiviral immunity through PCBP2 sumoylation-mediated MAVS degradation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

The kinase CK1ɛ controls the antiviral immune response by phosphorylating the signaling adaptor TRAF3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Non-canonical ubiquitylation: mechanisms and consequences.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

What Determines the Specificity and Outcomes of Ubiquitin Signaling?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Ubiquitin-specific proteases 25 negatively regulates virus-induced type I interferon signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

USP14 regulates autophagy by suppressing K63 ubiquitination of Beclin 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

USP14 deubiquitinates proteasome-bound substrates that are ubiquitinated at multiple sites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Facilitated Tau Degradation by USP14 Aptamers via Enhanced Proteasome Activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Deubiquitination of CXCR4 by USP14 is critical for both CXCL12-induced CXCR4 degradation and chemotaxis but not ERK ativation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Ubiquitin-specific protease 14 modulates degradation of cellular prion protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Reversible ubiquitination shapes NLRC5 function and modulates NF-κB activation switch

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Deubiquitinases regulate the activity of caspase-1 and interleukin-1β secretion via assembly of the inflammasome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Overexpression of USP14 protease reduces I-κB protein levels and increases cytokine release in lung epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Enhancement of proteasome activity by a small-molecule inhibitor of USP14

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Post-endocytotic Deubiquitination and Degradation of the Metabotropic γ-Aminobutyric Acid Receptor by the Ubiquitin-specific Protease 14.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Compensatory increase in USP14 activity accompanies impaired proteasomal proteolysis during aging

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Differential role of the proteasome in the early and late phases of BDNF-induced facilitation of LTP.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Molecular Basis and Regulation of OTULIN-LUBAC Interaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Viral deubiquitinases: role in evasion of anti-viral innate immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Genetic background alters the severity and onset of neuromuscular disease caused by the loss of ubiquitin-specific protease 14 (usp14)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

A catalytic independent function of the deubiquitinating enzyme USP14 regulates hippocampal synaptic short-term plasticity and vesicle number.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Ubiquitin-specific protease 14 regulates c-Jun N-terminal kinase signaling at the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Knockdown of Ubiquitin-Specific Protease 14 (USP14) Inhibits the Proliferation and Tumorigenesis in Esophageal Squamous Cell Carcinoma Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Ubiquitin-specific protease 14 regulates LPS-induced inflammation by increasing ERK1/2 phosphorylation and NF-κB activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

c-Cbl-mediated ubiquitination of IRF3 negatively regulates IFN-β production and cellular antiviral response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Guidelines for the use of flow cytometry and cell sorting in immunological studies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201847603

7 January 2021

Identifiers

DOI

10.1002/EJI.201847603

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30466171%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

1 reference